Edwards Lifesciences (EW) Target Lifted to $94 at Jefferies Post Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 7c, Updates Guidance
April 24, 2014 4:50 PM EDTEdwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.76, $0.07 better than the analyst estimate of $0.69. Revenue for the quarter came in at $522.4 million versus the consensus estimate of $523.1 million.
Edwards Lifesciences Corp. sees FY2014 EPS of $3.10, versus the consensus of $3.06. Edwards Lifesciences Corp.... More
